TIDMYGEN
Yourgene Health PLC
22 February 2021
Reach / Non-Regulatory Announcement
Yourgene Health plc
("Yourgene" or the "Group" or the "Company")
Partnership with NPH
To provide COVID-19 testing service for Leeds Bradford
Airport
Manchester, UK - 22 February 2021: Yourgene (AIM: YGEN), the
international molecular diagnostics group, announces that its
partnership with Newcastle Premier Health Limited(1) ("NPH"), a
leading provider of independent medical services in Newcastle and
the North East, will supply COVID-19 PCR testing services to Leeds
Bradford Airport from the Company's laboratory in Manchester.
Yourgene and NPH are partnering with Leeds Bradford Airport(2)
("LBA") to offer an onsite COVID-19 service for departing and
arriving passengers, and for the local community. NPH has
successfully implemented a similar testing service at Newcastle
Airport and will now look to mirror that offering at LBA , using
Yourgene's Clarigene(R) SARS-CoV-2 assay and its high throughput
COVID-19 service laboratory in Manchester to test samples taken at
the airport.
Together NPH and Yourgene will be offering 'Test To Release' for
arriving international travellers, 'Fit to Fly' test certificates
for departing passengers, and also general PCR coronavirus testing
for the general public that live in the surrounding region. This
testing service becomes available today at the airport in
anticipation of a relaxation of lockdown rules in the near future.
NPH is the sole provider of COVID-19 testing to LBA and Yourgene is
the sole COVID-19 testing provider to NPH for the LBA contract.
Yourgene Genomic Services is a UK Government approved COVID-19
private testing provider for the Test to Release for International
Travel scheme and for general coronavirus testing, as announced by
the Company on 24 December 2020.
Lyn Rees, CEO of Yourgene commented: "We are thrilled to be
partnering with NPH and Leeds Bradford Airport to offer our
accurate, reliable and trusted COVID-19 testing service. While the
timing of any lockdown relaxations and increases in passenger
traffic are unclear at present, we are primed for when these
restrictions are lifted at Leeds Bradford and other travel hubs
around the country.
"We are proud to be part of the global effort to fight this
pandemic by offering a high-class Genomics Services laboratories to
our partners."
(1) Newcastle Premier Health Limited is a leading provider of
independent medical services in Newcastle and the North East. The
Company's wide range of medical services includes General Practice
consultations, travel advice and immunisations, occupational health
assessments, medical screening, and work specific medical
assessments for pilots, divers, seafarers and offshore workers.
(2) Leeds Bradford Airport (LBA) is a regional travel hub used
by over 4 million travellers pre-pandemic.
Yourgene Health plc Tel: +44 (0)161 669 8122
Lyn Rees, Chief Executive Officer investors@yourgene-health.com
Barry Hextall, Chief Financial Officer
Joanne Cross, Director of Marketing
N+1 Singer (Joint Corporate Broker) Tel: +44 (0)20 7496 3000
Aubrey Powell / Tom Salvesen / George
Tzimas
Stifel Nicolaus Europe Limited (Joint Tel: +44 (0)20 7710 7600
Corporate Broker)
Nicholas Moore / Matthew Blawat / Ben
Maddison
Walbrook PR Ltd (Media and Investor Tel: +44 (0)20 7933 8780 or yourgene@walbrookpr.com
Relations)
Paul McManus / Lianne Cawthorne Mob: 07980 541 893 / Mob: 07584
391 303
About Yourgene Health
Yourgene Health is an international molecular diagnostics group
which develops and commercialises genetic products and services.
The group works in partnership with global leaders in DNA
technology to advance diagnostic science.
Yourgene primarily develops, manufactures, and commercialises
simple and accurate molecular diagnostic solutions, for
reproductive health, precision medicine and now infectious
diseases. The Group's flagship products include non-invasive
prenatal tests (NIPT) for Down's Syndrome and other genetic
disorders, Cystic Fibrosis screening tests, invasive rapid
aneuploidy tests, and a recent extension into the oncology space
with DPYD genotyping.
The launch of Yourgene Genomic Services has enabled Yourgene to
offer a global laboratory service network equipped to be a full
life-cycle partner for clinical, research and pharmaceutical
organisations to support partners at the preclinical, clinical, and
post-market stages to develop, manufacture, obtain regulatory
approval and commercialise new products and services. In addition,
Yourgene Genomic Services offers an NIPT and high throughput COVID
testing service.
In August 2020, Yourgene acquired Coastal Genomics, Inc., a
sample preparation technology company based in Vancouver, Canada,
enabling the Company to extend its offering and IP portfolio in the
DNA sample preparation sector. The acquisition increased Yourgene's
geographical penetration into the US and Canada, supplementing
existing coverage in the UK, Europe, MEA and Asia.
Yourgene Health is headquartered in Manchester, UK with offices
in Taipei, Singapore, the US and Canada, and is listed on the
London Stock Exchange's AIM market under the ticker "YGEN". For
more information visit www.yourgene-health.com and follow us on
twitter @Yourgene_Health.
This information is provided by Reach, the non-regulatory press
release distribution service of RNS, part of the London Stock
Exchange. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
Reach is a non-regulatory news service. By using this service an
issuer is confirming that the information contained within this
announcement is of a non-regulatory nature. Reach announcements are
identified with an orange label and the word "Reach" in the source
column of the News Explorer pages of London Stock Exchange's
website so that they are distinguished from the RNS UK regulatory
service. Other vendors subscribing for Reach press releases may use
a different method to distinguish Reach announcements from UK
regulatory news.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
NRATMMTTMTMTBAB
(END) Dow Jones Newswires
February 22, 2021 02:00 ET (07:00 GMT)
Yourgene Health (LSE:YGEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yourgene Health (LSE:YGEN)
Historical Stock Chart
From Apr 2023 to Apr 2024
